The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

PLoS ONE

Topics

Medicine

Internal Medicine

Endocrinology

Clinical Biochemistry

Endocrinology, Diabetes And Metabolism

Show all topics

DOI

10.1371/journal.pone.0112394

License

CC-BY

Other Formats

PDF